Convergence Investment Partners, LLC Eli Lilly & CO Transaction History

Convergence Investment Partners, LLC

$365 Million
Q3 2024

A detailed history of Convergence Investment Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Convergence Investment Partners, LLC holds 1,189 shares of LLY stock, worth $931,189. This represents 0.29% of its overall portfolio holdings.

Number of Shares

1,189

Previous 2,226 46.59%

Holding current value

$931,189

Previous $2.02 Million 47.74%

% of portfolio

0.29%

Previous 0.59%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$772.14 - $960.02 $800,709 - $995,540	-1,037 Reduced 46.59%	1,189 $1.05 Million
Q2 2024 Aug 01, 2024	BUY	$724.87 - $909.04 $50,740 - $63,632	70 Added 3.25%	2,226 $2.02 Million
Q1 2024 May 03, 2024	BUY	$592.2 - $792.28 $356,504 - $476,952	602 Added 38.74%	2,156 $1.68 Million
Q4 2023 Feb 05, 2024	BUY	$525.19 - $619.13 $70,900 - $83,582	135 Added 9.51%	1,554 $906,000
Q3 2023 Nov 02, 2023	BUY	$434.7 - $599.3 $7,824 - $10,787	18 Added 1.28%	1,419 $762,000
Q2 2023 Jul 26, 2023	SELL	$350.74 - $468.98 $18,238 - $24,386	-52 Reduced 3.58%	1,401 $657,000
Q1 2023 May 09, 2023	BUY	$310.63 - $364.82 $2,485 - $2,918	8 Added 0.55%	1,453 $499,000
Q4 2022 Feb 03, 2023	SELL	$321.55 - $374.67 $24,759 - $28,849	-77 Reduced 5.06%	1,445 $528,000
Q3 2022 Nov 08, 2022	SELL	$296.48 - $337.87 $30,833 - $35,138	-104 Reduced 6.4%	1,522 $492,000
Q2 2022 Aug 05, 2022	SELL	$278.73 - $327.27 $23,134 - $27,163	-83 Reduced 4.86%	1,626 $527,000
Q1 2022 Apr 26, 2022	SELL	$234.69 - $291.66 $2,816 - $3,499	-12 Reduced 0.7%	1,709 $489,000
Q4 2021 Jan 25, 2022	SELL	$224.85 - $279.04 $16,638 - $20,648	-74 Reduced 4.12%	1,721 $475,000
Q3 2021 Oct 25, 2021	SELL	$221.6 - $272.71 $17,728 - $21,816	-80 Reduced 4.27%	1,795 $415,000
Q2 2021 Jul 19, 2021	SELL	$180.55 - $233.54 $14,624 - $18,916	-81 Reduced 4.14%	1,875 $430,000
Q1 2021 Apr 30, 2021	SELL	$164.32 - $212.72 $5,093 - $6,594	-31 Reduced 1.56%	1,956 $365,000
Q4 2020 Feb 05, 2021	BUY	$130.46 - $172.63 $1,956 - $2,589	15 Added 0.76%	1,987 $336,000
Q3 2020 Oct 28, 2020	SELL	$146.22 - $169.13 $59,072 - $68,328	-404 Reduced 17.0%	1,972 $292,000
Q2 2020 Jul 30, 2020	BUY	$136.42 - $164.18 $9,685 - $11,656	71 Added 3.08%	2,376 $390,000
Q1 2020 Apr 23, 2020	SELL	$119.05 - $147.35 $19,167 - $23,723	-161 Reduced 6.53%	2,305 $320,000
Q4 2019 Jan 22, 2020	SELL	$106.92 - $132.43 $3,849 - $4,767	-36 Reduced 1.44%	2,466 $324,000
Q3 2019 Oct 22, 2019	BUY	$106.79 - $116.16 $640 - $696	6 Added 0.24%	2,502 $280,000
Q2 2019 Jul 23, 2019	SELL	$110.79 - $129.32 $1.13 Million - $1.32 Million	-10,170 Reduced 80.29%	2,496 $277,000
Q1 2019 May 01, 2019	BUY	$111.31 - $131.02 $1.15 Million - $1.35 Million	10,287 Added 432.41%	12,666 $1.64 Million
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $586,262 - $656,791	-5,536 Reduced 69.94%	2,379 $275,000
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $3.5 Million - $4.38 Million	-40,771 Reduced 83.74%	7,915 $849,000
Q2 2018 Aug 07, 2018	BUY	$75.7 - $86.88 $3.54 Million - $4.06 Million	46,729 Added 2387.79%	48,686 $4.15 Million
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $145,228 - $171,433	1,957 New	1,957 $151,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $744B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Convergence Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Convergence Investment Partners, LLC with notifications on news.

Account

Convergence Investment Partners, LLC Eli Lilly & CO Transaction History